Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias
Stopped Lack of accrual
Conditions
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Myeloproliferative Disorders
- Acute Lymphocytic Leukemia
- Acute Promyelocytic Leukemia
- Acute Leukemia
- Chronic Myelogenous Leukemia
- Myelofibrosis
- Chronic Myelomonocytic Leukemia
- Juvenile Myelomonocytic Leukemia
Interventions
- DRUG: Clofarabine
- DRUG: Cyclophosphamide
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators